ALTS-OP01 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,717 results for “ALTS-OP01”

Trials

View all 1114 →

Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS)

5,060 participants · First posted May 26, 2010

WP01 - Normothermic Liver Preservation

267 participants · First posted May 17, 2016

A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury

10 participants · First posted Feb 24, 2025

Drugs

View all 162 →

Investigational

RP01

Investigational

OPC1

O01

Organizations

View all 19 →

AlTi Global

United States

Altus Pharmaceuticals, Inc.

United States

ALTOS BIOLOGICS, INC.

South Korea

News

View all 422 →

Alteogen Receives Korean Approval for Aflibercept Biosimilar, Targeting Growing Retinal Disease Market

Imbria Pharmaceuticals Secures Extended Series B Funding to Advance First-in-Class Cardiovascular Therapy Ninerafaxstat

Cellogen Therapeutics Secures $2.4M to Advance Affordable CAR-T Cancer Therapies in India

Page 1 of 172